• Pocket Analyst Icon Logo
  • Sign up to save conversations
flag
ASX200
0.19%
RMD.AX logo
ResMed Inc.
US flag
ASX
31.23
AUD
+1.14+3.65%
45.30BMarket Cap
Health CareSector
Health Care SuppliesIndustry
Key Stats
Market Cap45.30B
PE Ratio (TTM)21.05
Dividend Yield (TTM)1.09%
Beta (1Y)0.87
SectorHealth Care
IndustryHealth Care Supplies
Details
Websiteresmed.com
CEOMichael J. Farrell
Description

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Dividends
0.09Latest Dividend
13 May 2026Ex. Date
14 May 2026Record Date
18 Jun 2026Payment Date
Past Dividends
Payout Ratio
Payout Ratio (TTM)
22.39%
Earnings Retained
77.61%

Financial information provided by Financial Modelling Prep. Logos provided by Logo.dev.

What's happening?
positive
Strategy Update
Aug 6, 2026

ResMed announced the sale of its MatrixCare software business for US$490 million. The divestment sharpens the company’s focus on its core sleep and breathing care franchise and is likely to be viewed positively by investors.

ResMed Inc. (RMD) Latest Stock News & Headlines - Yahoo Finance